| Mrs Himabindu Pitta, MD | |
|
1595 Soquel Dr Ste 400, Santa Cruz, CA 95065-1724 | |
| (831) 475-1111 | |
| (831) 476-5020 |
| Full Name | Mrs Himabindu Pitta |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 1595 Soquel Dr Ste 400, Santa Cruz, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619119997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A118485 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dominican Hospital | Santa cruz, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dignity Health Medical Foundation | 7810800661 | 1209 |
News Archive
A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.
Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.
An Australian scientist has discovered two new animal viruses, one in cattle and the other in mosquitoes - the unknown viruses were found in isolated regions of northern Australia - neither of the viruses cause disease in livestock.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
PhotoMedex, the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA® SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in dermatology offices nationwide and on NEOVA.com.
› Verified 7 days ago
| Entity Name | Dignity Health Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709 |
News Archive
A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.
Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.
An Australian scientist has discovered two new animal viruses, one in cattle and the other in mosquitoes - the unknown viruses were found in isolated regions of northern Australia - neither of the viruses cause disease in livestock.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
PhotoMedex, the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA® SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in dermatology offices nationwide and on NEOVA.com.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Himabindu Pitta, MD 3400 Data Dr, Attn: Credentialing/payer Enrollment, Rancho Cordova, CA 95670-7956 Ph: () - | Mrs Himabindu Pitta, MD 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065-1724 Ph: (831) 475-1111 |
News Archive
A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death.
Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.
An Australian scientist has discovered two new animal viruses, one in cattle and the other in mosquitoes - the unknown viruses were found in isolated regions of northern Australia - neither of the viruses cause disease in livestock.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
PhotoMedex, the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA® SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in dermatology offices nationwide and on NEOVA.com.
› Verified 7 days ago
Dr. Sabrina A Struve, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065 Phone: 831-475-1111 Fax: 831-476-5020 | |
Nhat Huu Hoang, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065 Phone: 831-475-1111 Fax: 831-476-5020 | |
John L Strutner, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065 Phone: 831-475-1111 Fax: 831-476-5020 | |
Dr. Miguel C Amurao, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065 Phone: 831-475-1111 Fax: 831-476-5020 | |
Eric Day, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 400, Santa Cruz, CA 95065 Phone: 831-475-1111 Fax: 831-476-5020 | |
Lindsy Elizabeth Martinez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2025 Soquel Ave, Santa Cruz, CA 95062 Phone: 831-458-5610 | |
Dr. Daniel Ryan Owyang, D.O Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2025 Soquel Ave, Santa Cruz, CA 95062 Phone: 831-423-1111 |